HWHaoling H. Weng
Haoling H. Weng
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Haoling H. Weng has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Cary O. Harding
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA
2 shared publications - Jerry Vockley
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, USA
2 shared publications - Joy Jiang
BioMarin Pharmaceutical Inc, 105 Digital Drive, Novato, CA, 94949, USA
2 shared publications - Markus Merilainen
BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA
2 shared publications - R. Stephen Amato
Pediatric Genetics and Metabolism, University of Kentucky, Lexington, KY 40506, USA
2 shared publications - Zhonghua Gu
BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA
2 shared publications
Latest Publications
- Open Access
- 1 May 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (1) , 27-38
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
- 1 May 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (1) , 27-38
Open AccessPegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
- Open Access
- 1 May 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (1) , 20-26
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
- 1 May 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (1) , 20-26
Open AccessPegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial